Novel anti-infective compounds from marine bacteria

Marine Drugs

Volumn 8, Issue 3, 2010, Pages 498-518

  Rahman, Hafizur ^a   Austin, Brian ^a,b   Mitchell, Wilfrid J ^a   Morris, Peter C ^a   Jamieson, Derek J ^a   Adams, David R ^a   Spragg, Andrew Mearns ^c   Schweizer, Michael ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

^c Aquapharm Biodiscovery Limited   (United Kingdom)

Author keywords

Antibiotic resistance; Hospital superbugs; Marine bacteria; MRSA; New scaffolds; Nosocomial infection; VRE

Indexed keywords

2,4 DIACETYLPHLOROGLUCINOL; ABYSSOMICIN B; ABYSSOMICIN C; ABYSSOMICIN D; ABYSSOMICIN G; ABYSSOMICIN H; ACTINOMYCIN V; ANTIINFECTIVE AGENT; BOGOROL A; LIPOXAZOLIDINONE A; LYDICAMYCIN; MARINOPYRROLE A; MARINOPYRROLE B; PENTABROMOPSEUDILIN; PLATENSIMYCIN; PSEUDOMONIC ACID; REBECCAMYCIN; STAUROSPORINE; TEICOPLANIN; THIOMARINOL A; THIOMARINOL B; THIOMARINOL C; THIOMARINOL D; THIOMARINOL E; THIOMARINOL F; THIOMARINOL G; TIRANDAMYCIN A; TIRANDAMYCIN B; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; BIOLOGICAL PRODUCT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ANTIBIOTIC RESISTANCE; ANTINEOPLASTIC ACTIVITY; BACTERICIDAL ACTIVITY; BURKHOLDERIA CEPACIA; CANDIDA ALBICANS; DRUG CYTOTOXICITY; DRUG STRUCTURE; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; MARINE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIA; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; ENTEROCOCCUS; ISOLATION AND PURIFICATION; MARINE BIOLOGY; MICROBIOLOGY;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; ENTEROCOCCUS; MARINE BIOLOGY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE; WATER MICROBIOLOGY;

EID: 77952481633     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8030498     Document Type: Review

References (93)

1. Michael, A.; Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science 2009, 325, 1089-1093.
2. Nathan, C. Antibiotics at the crossroads. Nature 2004, 431, 899-902.
3. Nussbaum, F.V.; Brands, M.; Hinzen, B.; Weigand, S.; Habich, D. Antibacterial natural products in medicinal chemistry - exodus or revival? Angew. Chem. Int. Ed. 2006, 45, 5072-5129.
4. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
5. Rahman, H. Unusual Sesquiterpenes: Gorgonenes and Further Bioactive Secondary Metabolites Derived from Marine and Terrestrial Bacteria. PhD Thesis, Universität Göttingen, Germany, 2008; p. 158.
6. Laatsch, H. AntiBase, A Data Base for Rapid Structural Determination of Microbial Natural Products, and annual updates, Wiley VCH: Weinheim, Germany, 2008.
7. Burkholder, P.R.; Pfister, R.M.; Leitz, F.H. Production of a pyrrole antibiotic by a marine bacterium. Appl. Microbiol. 1966, 14, 649-653.
8. Riedlinger, J.; Reicke, A.; Zähner, H.; Krismer, B.; Bull, A.T.; Maldonado, L.A.; Ward, A.C.; Goodfellow, M.; Bister, B.; Bischoff, D.; Süssmuth, R.D.; Fiedler, H.P. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. 2004, 57, 271-279.
9. Donia, M.; Hamann, M.T. Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis. 2003, 3, 338-348.
10. Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.
11. Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2002, 19, 1-48.
12. El Sayed, K.A.; Bartyzel, P.; Shen, X.; Perry, T.L.; Zjawiony, J.K.; Hamann, M.T. Marine natural products as antituberculosis agents. Tetrahedron 2000, 56, 949-953. (Pubitemid 30094161)
13. El Sayed, K.A. Natural products as antiviral agents. Stud. Nat. Prod. Chem. 2000, 24, 473-572.
14. Kayser, O.; Kiderlen, A.F.; Croft, S.L. Natural product as potential antiparasitic drugs. Stud. Nat. Prod. Chem. 2002, 26, 779-848.
15. Ghisalberti, E.L. Secondary metabolites with antinematodal activity. Stud. Nat. Prod. Chem. 2002, 26, 425-506.
16. Li, H-Y.;Matsunaga, S.; Fusetani, N. Antifungal metabolites from marine sponges. Curr. Org. Chem. 1998, 2, 649-682.
17. Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, J.M.; Craig, A.S.; Zell, E.R.; Fosheim, G.E.; McDougal, L. K.; Carey, R.B.; Fridkin, S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298, 1763-1771.
18. Huang, H.; Flynn, N.M.; King, J.H.; Monchaud, C; Morita, M.; Cohen, S.H. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. J. Clin. Microbiol. 2006, 44, 2423-2427.
19. Hiramatsu, K.; Okuma, K.; Hori, S.; Kapi, M. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Curr. Opin. Infect. Dis. 2002, 15, 407-413.
20. Witte, W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J. Antimicrob. Chemother. 1999, 44, 1-9.
21. Madani, T.A. Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the university hospital, Jeddah, Saudi Arabia. Can. J. Infect. Dis. 2002, 13, 245-250.
22. Hanaki, H.; Labischinski, H.; Inaba, Y.; Kondo, N.; Murakami, H.; Hiramatsu, K. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J. Antimicrob. Chemother. 1998, 42, 315-320.
23. Patersen, D.L. Reduced susceptibility of Staphylococcus aureus to vancomycin - a review of current knowledge Commun. Dis. Intell. 1999, 24, 69-73.
24. Mainardi, J.L.; Shlaes, D.M.; Goering, R.V.; Shlaes, J.H.; Acar, J.F.; Goldstein, F.W. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 1995, 171, 1646-1650.
25. Vaudaux, P.; Francois, P.; Berger-Bachi, B.; Lew, D.P. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J. Antimicrob. Chemother. 2001, 47, 163-170.
26. Leclerq, R.; Derlot, E.; Duval, J.; Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 1988, 319, 157-161.
27. Weigel, L.M.; Clewell, D.B.; Gill, S.R.; Clark, N.C.; McDougal, I.M.; Flannagan, S.E.; Kolonay, J.F.; Shetty, J.; Killgore, G.E.; Tenover, F.C. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003, 302, 1569-1571.
28. Edmond, M.B.; Ober, J.F.; Weinbaum, D.L.; Pfaller, M.A.; Hwang, T.; Sanford, M.D.; Wenzel, R.P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 1995, 20, 1126-1133.
29. Hughes, C.C.; Prieto-Davo, A.; Jensen, P.R.; Fenical, W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org. Lett. 2008, 10, 629-631.
30. Shiozawa, H.; Shimada, A.; Takahashi, S. Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J Antibiot. 1997, 50, 449-452.
31. Shiozawa, H.; Kagasaki, T.; Kinoshita, T.; Haruyama, H.; Domon, H.; Utsui, Y.; Kodama, K.; Takahashi, S. Thiomarinol, a hybrid antimicrobial antibiotic produced by a marine bacterium fermentation, isolation , structure and antimicrobial activity. J. Antibiot. 1993, 46, 1834-1842.
32. Shiozawa, H.; Takahashi, S. Configurational studied on thiomarinol. J. Antibiot. 1994, 47, 851-853.
33. Shiozawa, H.; Kagasaki, T.; Torikata, A.; Tanaka, N.; Fujimoto, K.; Hata, T.; Furukawa, Y.; Takahashi, S. Thiomarinol B, thiomarinol C, new antimicrobial antibiotics produced by a marine bacterium. J. Antibiot. 1995, 48, 907-909.
34. Fuller, A.T.; Mellows, G.; Woolford, M.; Banks, G.T.; Barrow, K.D.; and Chain, E.B. Pseudomonic acid - antibiotic produced by Pseudomonas fluorescens. Nature 1971, 234, 416.
35. Hughes, J.; Mellows, G. Interaction of pseudomonic acid A with Escherichia coli B-isoleucyl transfer RNA synthetase. Biochem. J. 1980, 191, 209-219. (Pubitemid 11198152)
36. Isnansetyo, A.; Kamei, Y. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T. Int. J. Antimicrob. Agents 2009, 34, 131-135.
37. Harada, H.; Kamei, Y. Selective cytotoxicity of marine algae extract to several human leukemic cell lines. Cytotechnology 1997, 25, 213-219. (Pubitemid 28110882)
38. Isnansetyo, A.; Kamei, Y. MC21-A, a bactericidal antibiotic against methicillin-resistant Staphylococcus aureus. Antimicrob. Ag. Chemother. 2003, 47, 480-488.
39. Yoongho, L; Jun-Hwan C.;, Jong-Hoon K.; Jung-Woo S.; Jae-Kyung J.; Chul-Hoon L. Structure elucidation of a potent anti-MRSA antibiotic AM3, produced by Streptomyces sp. Han'guk Nonghwa Hakhoechi 1995, 38, 516-521.
40. Keller, S.; Nicholson, G.; Drahl, C.; Sorensen, E.;. Fiedler, H.P.; Süssmuth, R.D. Abyssomicins G and H and atrop-abyssomicin C from the marine Verrucosispora strain AB-18-032. J. Antibiot. 2007, 60, 391-394.
41. Bister, B.; Bischoff, D.; Strobele, M.; Riedlinger, J.; Reicke, A.; Wolter, F.; Bull, A.T.; Zahner, H.; Fiedler H.P.; Süssmuth, R.D.. Abyssomicin C-a polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew. Chem. Int. Edit. 2004, 43, 2574-2576.
42. Nicolaou, K.C.; Harrison S.T. Total synthesis of abyssomicin C and atrop-abyssomicin C. Angew. Chem. Int. Ed. 2006, 45, 3256-3260.
43. Zapf, C.W.; Harrison, B.A.; Drahl, C.; Sorensen, E.J. A Diels-Alder macrocyclization enables an efficient asymmetric synthesis of the antibacterial natural product abyssomicin C. Angew. Chem. Int. Ed. 2005, 44, 6533-6537.
44. Peters, R.; Fischer, D.F. Total syntheses of the antibacterial natural product abyssomicin C. Angew. Chem. Int. Ed. 2006, 45, 5736-5739.
45. Niu, X.M.; Li, S.H.; Gorls, H.; Schollmeyer, D.; Hilliger, M.; Grabley, S.; Sattler, I. Abyssomicin E, a highly functionalized polycyclic metabolite from Streptomyces species. Org. Lett. 2007, 9, 2437-2440.
46. Nicolaou, K.C.; Harrison, S.T. Total synthesis of abyssomicin C, atrop-abyssomicin C, and abyssomicin D: implications for natural origins of atrop-abyssomicin C. J. Am. Chem. Soc. 2007, 129, 429-440.
47. Keller, S.; Schadt, H.S.; Ortel, I.; Süssmuth, R.D.. Action of atrop-abyssomicin C as an inhibitor of 4-amino-4-deoxychorismate synthase PabB. Angew. Chem. Int. Ed. 2007, 46, 8284-8286.
48. Bartlett, P.A.; Johnson, C.R. An inhibitor of chorismate mutase resembling the transition state conformation. J. Am. Chem. Soc. 1985, 107, 7792-7793.
49. Furumai, T.; Eto, K.; Sasaki, T.; Higuchi, H.; Onaka, H.; Saito, N.; Fujita, T.; Naoki, H.; Igarashi, Y. TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. J. Antibiot. 2002, 55, 873-880.
50. Hayakawa, Y.; Kanamaru, N.; Shimazu, A.; Seto, H. Lydicamycin, a new antibiotic of a novel skeletal type. I. Taxonomy, fermentation, isolation and biological activity. J. Antibiot. 1991, 44, 282-287.
51. Hayakawa, Y.; Kanamaru, N.; Morisaki, N.; Furihata, K.; Seto, H. Lydicamycin, a new antibiotic of a novel skeletal type. II. Physico-chemical properties and structure elucidation. J. Antibiot. 1991, 44, 288-292.
52. Kushida, H.; Nakajima, S.; Koyama, T.; Suzuki, H.; Ojiri, K.; Suda, H. Antitumoric BE-43472 manufacture with streptomyces. 1996, JP 08143569.
53. Socha, A.M.; Garcia, D.; Sheffer, R.; Rowley, D.C. Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata. J. Nat. Prod. 2006, 69, 1070-1073.
54. Socha, A.M.; LaPlante, K.L.; Rowley, D.C. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates Bioorg. Med. Chem. 2006, 14, 8446-8454.
55. Nicolaou, K.C.; Lim, Y.H.; Becker, J. Total synthesis and absolute configuration of the bisanthraquinone antibiotic BE-43472B. Angew. Chem. Int. Ed. 2009, 48, 3444-3448.
56. Nicolaou, K.C.; Becker, J.; Lim, Y.H.; Lemire, A.; Neubauer, T.; Montero, A. Total synthesis and biological evaluation of (+)- and (-)-bisanthraquinone antibiotic BE-43472B and related compounds. J. Am. Chem. Soc. 2009, 131, 14812-14826.
57. Michelle, S.; Teisan S.; Tsueng, G.; Venkat, M.; Kin, L. Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920. J. Ind. Microb. Biotech. 2008, 35, 761-765.
58. Macherla, V.R.; Liu, J.N.; Sunga, M.; White, D.J.; Grodberg, J.; Teisan, S.; Lam, K.S.; Potts, B.C.M. Lipoxazolidinones A, B, and C: antibacterial 4-oxazolidinones from a marine actinomycete isolates from a Guam marine sediment. J. Nat. Prod. 2007, 70, 1454-1457.
59. Maya, S,P.; Kong, F.; Jeffrey J.E; Daniel A.A.; Paola S.A.; Valerie B.S.; Peter P.J.; Weiss W.J.; Carter, G.; Greenstein, M. Novel alpha-pyrones produced by a marine Pseudomonas sp. F92S91: taxonomy and biological activities. J. Antibiot. 2003, 56, 1033-1044.
60. Kamei, Y.; Isnansetyo, A. Lysis of methicillin-resistant Staphylococcus aureus by 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga. Int. J. Antimicrob. Agents 2003, 21, 71-74.
61. Isnansetyo, A.; Longzhu, C.; Keiichi, H.; Kamei, Y. Antibacterial activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine algae, against vancomycin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 2003, 22, 545-547.
62. Isnansetyo, A.; Horikawa, M.; Kamei, Y. In vitro anti-methicillin resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by a Pseudomonas sp AMSN isolated from a marine alga. J. Antimicrob. Chemother. 2001, 47, 724-725.
63. Wang, J.; Soisson, S.M.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; Parthasarathy, G.; Tang, Y.S.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya, H.; Ondeyka, J.; Herath, K.; Zhang, C.; Hernandez, L.; Allocco, J.; Basilio, Á.; Tormo, J.R.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S.H.; Michael, B.; Felcetto, T.; Gill, C.; Silver, L.L.; Hermes, J.D.; Bartizal, K.; Barrett, J.; Schmatz, D.; Becker, J.W.; Cully, D.; Singh, S.B. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006, 441, 358-361.
64. Abdelfattah M.S. New Secondary Metabolites from Bacteria: Seitomycin with high Anti-Helicobacter pylori Activity, Exfoliazone B, new Steffimycinones, Espicufolin B, Flavomarine A and B, and BS-46 with a Novel Carbon Skeleton. PhD Thesis, Universität Göttingen, 2005.
65. Brinster, S.; Lamberet, G.; Staels, B.; Trieu-Cuot, P.; Gruss, A.; Poyart, C. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009, 458, 83-85.
66. Barsby, T.; Kelly, M. T.; Gagne, S. M.; Andersen, R. J. Bogorol A, produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics. Org. Lett. 2001, 3, 437-440.
67. Gerard, J. M.; Haden, P.; Kelly, M. T.; Andersen, R. J. Loloatins A-D, cyclic decapeptide antibiotics produced in culture by a tropical marine bacterium J. Nat. Prod. 1999, 62, 80-85.
68. Gerard, J.; Haden, P.; Kelly, M.T.; Andersen, R.J. Loloatin B, a cyclic decapeptide antibiotic produced in culture by a tropical marine bacterium. Tetrahedron Lett. 1996, 37, 7201-7204.
69. Krachkovskii, S.A.; Sobol, A.G.; Ovchinnikova, T.V.; Tagaev, A.A.; Yakimenko, Z.A.; Azizbekyan, R.R.; Kuznetsova, N.I.; Shamshina, T.N.; Arseniev, A.S. The isolation, biological properties, and spatial structure of antibiotic loloatin A. Russ. J. Bioorg. Chem. 2002, 28, 269-273.
70. Chen, H.; Haynes, R.K.; Scherkenbeck, J. Synthesis of cyclic hexapeptides based on the antibiotic cyclice decapeptide loloatin C by an in situ indirect cyclization method. Eur. J. Org. Chem. 2004, 1, 38-47.
71. Chen, H.; Haynes, R.K.; Scherkenbeck, J.; Sze. K.H.; Zhu, G. Elucidation of the solution conformations of loloatin C by NMR spectroscopy and molecular simulation. Eur. J. Org. Chem. 2004, 31-37.
72. Chen, H.R.; Guo. X.K. Study of the conformation of cyclodecapeptide loloatin C with obvious antibiotic activity. Chinese J. Struct. Chem. 2005, 24, 273-278.
73. Chen, H.R.; Guo, X.K.; Zhong, X.B. Synthesis of aladan and [Ald(6)]loloactin C and study of their fluorescent properties. Chin. J. Chem. 2006, 24, 1411-1417.
74. Tuin, A.W.; Grotenbreg, G.M.; Spalburg, E.; de Neeling, A.J.; Mars-Groenendijk, R.H.; van der Marel, G.A.; Noort, D.; Overkleeft, H.S.; Overhand, M. Structural and biological evaluation of some loloatin C analogues. Bioorg. Med. Chem. 2009, 17, 6233-6240.
75. Kwon, H.C.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "Marinispora". J. Am. Chem. Soc. 2006, 128, 1622-1632.
76. Needham, J.; Kelly, M.T.; Ishige, M.; Andersen, R.J. Andrimid and moiramides A- C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis. J. Org. Chem. 1994, 59, 2058-2063.
77. Fredenhagen, A.; Tamura, S.Y.; Kenny, P.T.M.; Komura, H.; Naya, Y.; Nakanishi, K.; Nishiyama, K.; Sugiura, M.; Kita, H. Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper. J. Am. Chem. Soc. 1987, 109, 4409-4411.
78. McWhorter, W.; Fredenhagen, A.; Nakanishi, K.; Komura, H. Stereocontrolled synthesis of andrimid and a structural requirement for the activity. J. Chem. Soc., Chem. Commun. 1989, 5, 299-301.
79. Carlson, J.C.; Li, S.; Burr, D.A.; Sherman, D.H. Isolation and characterization of tirandamycins from a marine- derived Streptomyces sp. J. Nat. Prod. 2009, 72, 2076-2079.
80. Hagenmaier, H.; Jaschke, K.H.; Santo, L.; Scheer, M.; Zahner, H. Metabolic products of microorganisms. 158. Tiransamycin B. Arch. Microbiol. 1976, 109, 65-74.
81. Meyer, C.E. Tirandamycin, a new antibiotic isolation and characterization. J. Antibiot. 1971, 24, 558-560.
82. McArthur, K.A.; Mitchell, S.S.; Tsueng, G.; Rheingold, A.; White, D.J.; Grodberg, J.; Lam, K.S.; Potts, B.C.M. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J. Nat. Prod. 2008, 71, 1732-1737.
83. Omura, S.; Iwai, Y.; Hirano, A.; Nakagawa, A.; Awaya, J.; Tsuchiya, H.; Takahashi, Y.; Masuma, R. New alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization. J. Antibiot. 1977, 30, 275-282.
84. Bush, J.A.; Long, B.H.; Catino, J.J.; Bradner, W.T. Production and biological activity of rebeccamycin, a novel antitumor agent. J. Antibiot. 1987, 40, 668-678. (Pubitemid 17072164)
85. Hoshino, T.; Kojima, Y.; Hayashi, T.; Uchiyama, T.; Kaneko, K. Studies on the biosynthesis of violacein. 4. A new metabolite of tryptophan, chromopyrrolic acid, produced by Chromobacterium violaceum. Biosci. Biotech. Biochem. 1993, 57, 775-781.
86. Frode, R.; Hinze, C.; Josten, I.; Schmidt, B.; Steffan, B.; Steglich, W. Isolation and synthesis of 3,4-bis(indol-3-yl)pyrroles-2,5-dicarboxylic acid derivatives from the slime mold Lycogala epidendrum. Tetrahedron Lett. 1994, 35, 1689-1690. (Pubitemid 24124122)
87. Hashimoto, T.; Yasuda, A.; Akazawa, K.; Takaoka, S.; Tori, M.; Asakawa, Y. 3 novel dimethyl pyrroledicarboxylate, lycogarubins A-C, from the myxomycetes Lycogala epidendrum. Tetrahedron Lett. 1994, 35, 2559-2560. (Pubitemid 24144551)
88. Cueto, M.; Jensen, P.R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J. Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge J. Nat. Prod. 2001, 64, 1444-1446.
89. Yan, L.M.; Boyd, K.G.; Adams, D.R.; Burgess, J.G. Biofilm specific cross-species induction of antimicrobial compounds in bacilli. Appl. Environ. Microbiol. 2003, 69, 3719-3727.
90. Berdy, J. Bioactive microbial metabolites - a personal view. J. Antibiot. 2005, 58, 1-26. (Pubitemid 40299637)
91. Boyd, K.G.; Adams, D.R.; Burgess, J.G. Antibacterial and repellent activities of marine bacteria associated with algal surfaces. Biofouling 1999, 14, 227-236.
92. Mearns-Spragg, A.; Bregu, M.; Boyd, K.G.; Burgess, J.G. Cross-species induction and enhancement of antibiotic production by epiphytic bacteria from marine algae and invertebrates, after exposure to terrestrial bacteria. Lett. Appl. Microbiol. 1998, 27, 142-146.
93. Induction of microbial secondary metabolites. SeaRch® technology platform. Priority Application GB0600844.5.